The detection of diseases in an early stage of development gives many advantages such as a timely and custom made treatment with significant cost savings and the possibility for tracing the cause of the disease. To support the progress in the field of early diagnostics, VITO focusses on the development of biomolecular analytical technologies and the discovery of biomarkers for the healthcare industry and professionals.